About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Austin | 7,647 Studies Near You

Clinical TrialsAustin

Clinical Trials in Austin

Discover 7,647 clinical trials near Austin, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5141-5160 of 7,647 trials

Active not recruitingPhysician/Patient Choice of Either High-Dose Recombinant Interferon Alfa-2B or Ipilimumab, Versus Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by SurgeryThis randomized phase III trial studies how well pembrolizumab works compared with the current standard of care, physician/patient choice of either high-dose recombinant…NCT02506153·Birmingham, Alabama and 575 others

Find Trials by Condition in Austin

Breast Cancerin Austin Lung Cancerin Austin Prostate Cancerin Austin Colorectal Cancerin Austin Melanomain Austin Leukemiain Austin Lymphomain Austin Pancreatic Cancerin Austin Ovarian Cancerin Austin Brain Cancerin Austin Diabetesin Austin

Data from ClinicalTrials.govTerms

Active not recruitingScreening for High Frequency Malignant DiseaseThe SHIELD (Screening for High Frequency Malignant Disease) study is a prospective, observational, multi-site basket design trial without randomization.NCT05117840·Birmingham, Alabama and 142 others

CompletedA Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Sugar and Body Weight in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 InhibitorThe study will look at how well CagriSema helps people lower their blood sugar and body weight.NCT06065540·Birmingham, Alabama and 404 others

CompletedA Pilot Study of OSI-461 in Patients With Chronic Lymphocytic Leukemia (CLL)The objectives of this study are to evaluate the safety and efficacy of OSI-461 in CLL patients.NCT00073489·Phoenix, Arizona and 14 others

CompletedPrompt Panretinal Photocoagulation Versus Ranibizumab+Deferred Panretinal Photocoagulation for Proliferative Diabetic RetinopathyThe primary objective of the protocol is to determine if visual acuity outcomes at 2 years in eyes with proliferative diabetic retinopathy (PDR) that receive anti-vascular…NCT01489189·Phoenix, Arizona and 47 others

CompletedBioequivalency Study of 5 mg Pilocarpine Tablets Under Fasting ConditionsThe objective of this study was the bioequivalence of a Roxane Laboratories' Pilocarpine Tablets, 5 mg, to SALAGEN® Tablets, 5 mg (MGI Pharma) under fasting conditions using a…NCT00601874·Austin, Texas

CompletedA Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic DermatitisThis study will evaluate upadacitinib compared to dupilumab (Dupixent®) in adults with moderate to severe atopic dermatitis (AD) who are candidates for systemic therapy.NCT03738397·Birmingham, Alabama and 158 others

CompletedA Bioavailability Study Comparing Treprostinil Diethanolamine Oral Tablets and Oral Solution in Healthy VolunteersThis single center, open label, randomized, two-period, two-sequence cross-over study is designed to evaluate the relative bioavailability of a treprostinil diethanolamine 1 mg…NCT01172496·Austin, Texas

CompletedA Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)The safety and efficacy of multiple dosages of TD-9855, administered once daily, will be evaluated in adult males with ADHD.NCT01458340·Bradenton, Florida and 16 others

TerminatedA Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell LymphomaTo evaluate the safety and efficacy of lenalidomide (Revlimid ®) in combination with dexamethasone in subjects with relapsed or refractory diffuse large B-cell lymphoma.NCT00474188·Glendale, Arizona and 23 others

CompletedLong-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With PsoriasisThe main purpose of this study is to evaluate the long-term safety and efficacy of the drug Deucravacitinib (BMS-986165) in participants who have been previously enrolled in an…NCT04036435·Birmingham, Alabama and 301 others

CompletedA Multi-Center Trial to Compare Three Doses of Meloxicam and Placebo in Patients With Rheumatoid ArthritisA 12-week trial consisting of 5 visits (6 if follow up is needed) to find out how effective and safe three different doses of meloxicam are compared with placebo in Rheumatoid…NCT00042068·Huntsville, Alabama and 152 others

CompletedPhase I Study of the Volitinib (HMPL-504) in Patients With Advanced Solid TumorsVolitinib (HMPL-504) is a novel, highly potent and selective small molecule inhibitor of c-Met kinase.NCT01773018·Nedlands, Western Australia and 2 others

CompletedSafety Study of SGN-CD70A in Cancer PatientsThis study will examine the safety profile of SGN-CD70A.NCT02216890·Birmingham, Alabama and 16 others

CompletedEfficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) TherapyThe purpose of this study is to evaluate the safety, efficacy, pharmacokinetics, and immunogenicity of CDP6038 treatment in adult subjects with active rheumatoid arthritis who…NCT01242488·Mesa, Arizona and 81 others

CompletedOpen Label Extension Study of Epratuzumab in Subjects With Systemic Lupus ErythematosusThe primary objective of the study is assess the safety and tolerability of long-term epratuzumab treatment in subjects with Systemic Lupus Erythematosus (SLE)NCT01408576·Birmingham, Alabama and 227 others

Not yet recruitingOLIG2 Inhibitor CT-179 for Recurrent and Newly-diagnosed GlioblastomaThis is a first-in-human Phase 1 two-part, open-label, multi-center, dose escalation study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics…NCT07739017·Herston, Queensland and 1 other

CompletedComparison of Two Pulmonary Embolism TreatmentsThe primary objective of this trial is to evaluate the safety and efficacy of treatment with anticoagulation alone versus anticoagulation and mechanical aspiration thrombectomy…NCT05684796·Tucson, Arizona and 21 others

CompletedBioequivalency Study of Zidovudine Under Fasting ConditionsThe objective of this study was to assess the bioequivalence of Roxane's zidovudine 300 mg tablet compared to GlaxoSmithKline's Retrovir® 300 mg tablet under fasting conditions…NCT00602550·Austin, Texas

RecruitingRole of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Immunoglobulin Stopping or Extension (Stop Ig)This study is being conducted to find out how safe and effective different strategies of infection prevention are in comparison to each other, for preventing infection in patients…NCT07202091·Adelaide, South Australia and 2 others

PreviousPage 258 of 383Next

Heart Diseasein Austin